Published in JAMA 3rd October: Repurposed cardiac sodium channel blocker brings significant benefit for patients with a rare neuromuscular disease. An international multi-centred trial published in the leading medical jo - Mexiletine - Document - PDFSEARCH.IO

First Page	Meta Content
	Published in JAMA 3rd October: Repurposed cardiac sodium channel blocker brings significant benefit for patients with a rare neuromuscular disease. An international multi-centred trial published in the leading medical jo Add to Reading List Document Date: 2013-01-02 10:11:36 Open Document File Size: 247,24 KB Share Result on Facebook Country United Kingdom / / IndustryTerm rare disease networks / / MedicalCondition rare neuromuscular disease / pain / myotonia / myotonia and quantitative grip myotonia / fatigue / rare diseases / rare genetic neurological disorder / disorder / rare disease / non-dystrophic myotonia / / MedicalTreatment relaxation / / Organization MRC Centre for Neuromuscular Diseases / American Medical Association / / Person Michael Hanna / Dipa Raja Rayan / / Position Professor / Director / / PublishedMedium The Journal of the American Medical Association / / URL http / SocialTag Electrophysiology Ion channels Sodium Medicine Myotonia Myopathy Mexiletine Nav1.4 Sodium channel Health

Published in JAMA 3rd October: Repurposed cardiac sodium channel blocker brings significant benefit for patients with a rare neuromuscular disease. An international multi-centred trial published in the leading medical joAdd to Reading List